Metraipolis › archive › dc_95d580f11751

Avax Technologies — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Avax_Technologies
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-10T12:35:45.858Z
SHA-256 of the archived text
318ac99dfe85512890a361978f4f56fdb013e32fd25b78e6dab03eb14e8bd847
Stable URL of this page
https://metraipolis.com/documento/dc_95d580f11751

How to cite

Avax Technologies — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Avax_Technologies (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_95d580f11751 (Metraipolis archive dc_95d580f11751, sha256 318ac99dfe85512890a361978f4f56fdb013e32fd25b78e6dab03eb14e8bd847)
BibTeX
@misc{dc95d580f11751,
  title = {Avax Technologies — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Avax_Technologies},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_95d580f11751; sha256 318ac99dfe85512890a361978f4f56fdb013e32fd25b78e6dab03eb14e8bd847},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Avax_Technologies. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Avax Technologies, Inc. is a Philadelphia-based biotechnology company whose most advanced product candidate is MVax for melanoma. MVax is a cancer vaccine that received a Special Protocol Assessment agreement with the FDA in October 2006, and subsequently began a Phase III registration clinical trial in November 2007. In previous studies, MVax demonstrated a 5-year overall survival rate (OS)of 44% and response rate of 35% (13% CR, 22% PR).

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Avax Technologies» — https://en.wikipedia.org/wiki/Avax_Technologies
Wikidata Q4827853: «Philadelphia based biotechnology company» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q4827853
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Avax_Technologies?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1363967309, consultata il 2026-11-10T12:32:17.929Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 2d7c2e5c943495b09937049481aafed1eb50dd008fee40f1e697b5cdc73019b1